ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Hop Oil: A Safe Sleep Aide

Lutein — An Important Nutrient for Eye and Brain Health

White Camphor Oil: The Purest Camphor Oil

Taurine: Facts About This Crucial Amino Acid

 
Print Page
Email Article

Ampligen Trials for Chronic Fatigue Syndrome Expanded

  [ 32 votes ]   [ Discuss This Article ]
By Sources: PR Newswire, Philadelphia, PA. April 8, 1 • www.ProHealth.com • April 8, 1999


Hemispherx Receives FDA Approval To Expand CFS Program - Number of Patients More Than Double in Cost-Recovery Treatment

Hemispherx Biopharma, Inc. today [April 8, 1999] said that it has received authorization from the Food and Drug Administration (FDA) to more than double the number of patients undergoing treatment in its cost-recovery program for Chronic Fatigue Syndrome (CFS).

In the first quarter, Hemispherx announced that active treatment of patients in a confirmatory Phase III clinical trial of its drug Ampligen® was underway in a 40-week protocol that involved placebo-controlled, double-blind testing.

Today's announcement concerns the parallel clinical activity in the U.S. in which now more than 100 patients suffering from severely debilitating CFS will pay for Ampligen® to be used during the clinical program. The company said that a key part of its drug development strategy has been to use various incentives that the FDA has made available to Hemispherx, including this cost recovery program.

With the new FDA authorization, it is estimated that more than 200 patients with CFS, which is also known as Myalgic Encephalomyelitis (ME) in Europe, are involved in the combined programs. Patients are currently being evaluated in San Diego/Los Angeles/Irvine/San Francisco Bay, California; Incline Village, Nevada; Tulsa, Oklahoma; Miami/Hollywood, Florida; Chicago; Salt Lake City; Charlotte, North Carolina; Philadelphia/Delaware Valley region, Pennsylvania; Montgomery, Alabama; Washington, D.C.; New York City and three sites in the New York City/Long Island/Northern New Jersey area. These sites represent the top CFS/ME investigators in the United States.

Hemispherx, which is based in Philadelphia, also has offices in Brussels, Belgium, and antiviral drug development facilities in Rockville, Maryland. At the end of last year, Hemispherx Biopharma Europe, a subsidiary company, filed a full marketing application in Brussels and London that covers the 15-country membership in the European Union. The Company also has said that additional applications for full marketing approval in other countries are expected, based on clinical results to date.

Patients not eligible for the Phase III confirmatory trial in the U.S. may seek treatment under the expanded treatment protocol administered by Hemispherx and Olsten Health Services, a subsidiary of Olsten Corporation. Timely information can be obtained on a Hotline at 888-559-4623, managed by Olsten Health Care.

To the company's knowledge, Hemispherx is the only company with authorized Phase III studies in the U.S. for CFS and the only company with a pending application for full marketing approval in any major pharmaceutical market world-wide. The Centers for Disease Control estimates that CFS affects approximately 500,000 Americans and various medical studies suggest a similar number of Europeans are affected as well.

Hemispherx Biopharma is a pharmaceutical company engaged in the manufacture and global clinical development of new drug entities in the nucleic acid (NA) class for chronic viral diseases and disorders of the immune system including CFS, hepatitis B and hepatitis C.

Information contained in this news release, other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed in this release and in the company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements.

Sources:
PR Newswire, Philadelphia, PA. April 8, 1999.



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Optimized Curcumin Longvida® Ultra EPA  - Fish Oil


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

The Remarkable Benefits of Reishi Medicinal Mushrooms The Remarkable Benefits of Reishi Medicinal Mushrooms
Live Without Anxiety or Stress Live Without Anxiety or Stress
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea
Break Free From Fibromyalgia Break Free From Fibromyalgia
The Fast-Acting Solution for Healthy Digestive Function The Fast-Acting Solution for Healthy Digestive Function

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map